(NASDAQ: VIR) Vir Biotechnology's forecast annual revenue growth rate of 9.3% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.84%.
Vir Biotechnology's revenue in 2025 is $78,618,000.On average, 3 Wall Street analysts forecast VIR's revenue for 2025 to be $8,137,055,570, with the lowest VIR revenue forecast at $1,660,904,647, and the highest VIR revenue forecast at $14,625,876,744. On average, 3 Wall Street analysts forecast VIR's revenue for 2026 to be $7,153,458,473, with the lowest VIR revenue forecast at $1,744,913,920, and the highest VIR revenue forecast at $12,477,442,872.
In 2027, VIR is forecast to generate $16,526,414,400 in revenue, with the lowest revenue forecast at $12,229,546,656 and the highest revenue forecast at $20,823,282,144.